Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine SR in Chronic Heart Failure with LV Systolic Dysfunction
CTR20132240Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in heart failure with reduced ejection fraction (HFrEF), sponsored by Hengrui Therapeutics. Started Aug 2014; status: completed.
02
Drugs
ivabradine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on CTR20132240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132240.